Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- NAFLD
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Hepatic Fibrosis and Cardiovascular Risk are evaluated by non invasive tests
Hepatic Fibrosis and Cardiovascular Risk are evaluated by non invasive tests
Tracking Information
- NCT #
- NCT04774302
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Maeva GUILLAUME, MD Clinique Pasteur